ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Biologically Informed Vision-Guided Framework for Interpretable T Cell Receptor-Epitope Binding Prediction.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MHCXGraph: a graph-based approach to detecting T-cell receptor cross-reactivity.Briefings in bioinformatics · 2026Article
- Cross-task interpretability through unified modeling reveals a universal shortcut bias in neoantigen prediction.Cell genomics · 2026Article
- Intelligent antigen design combined with yeast display enhances targeted immune responses.Briefings in bioinformatics · 2026Article
- Modeling TCR-Epitope Recognition Specificity: What We Should Learn to Succeed.Immunological reviews · 2026Review
- A Biologically Informed Vision-Guided Framework for Interpretable T Cell Receptor-Epitope Binding Prediction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate identification of the interactions between T-cell receptors (TCRs) and antigenic epitopes presented by major histocompatibility complex (MHC) molecules is fundamental to advancing cancer immunotherapy. Nevertheless, predictive modeling of TCR-epitope binding remains challenging, as existing models struggle to generalize to unseen epitopes while often overlooking key physicochemical properties governing immune recognition. Here, a biologically informed vision-guided deep learning framework (DAISY) is proposed for robust and interpretable TCR-epitope binding prediction. DAISY integrates hierarchical physicochemical features via a biologically inspired Condition-Adaptive Fusion module, jointly modeling residue-level spatial interactions and global biochemical context. DAISY consistently outperforms state-of-the-art models across four generalization scenarios, notably improving ROC-AUC by 11% and PR-AUC by 16% over the strongest competitor in the most challenging Unseen-Pair setting. DAISY also offers intuitive interpretability by localizing interaction-relevant residues via Score-CAM visualizations. Furthermore, its computational predictions are bridged to key immunological and clinical outcomes, demonstrating utility in correlating with T-cell clonal expansion, identifying functional TCRs, and robustly forecasting patient survival. Together, DAISY can serve as a powerful tool for broad translational immunology and introduces a scalable modeling paradigm for next-generation immune modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.